Eniko Toke
Chief Scientific Officer Treos Bio
Dr Enikő Tőke is the Co-Founder and Chief Scientific Officer of Treos Bio, with over 20 years of experience in translational biomedical research. She specialises in developing immunotherapies for cancer, infectious diseases, and allergies, and is a co-inventor of the company’s core technologies, with several programs progressing toward clinical application.
Seminars
Wednesday 22nd July 2026
Evaluation of HLA Genotype as Predictive Biomarkers for Immunological & Clinical Responses Upon Vaccination with PolyPEPI Vaccines
11:00 am
- Highlighting a novel vaccine platform used to develop both off-the-shelf and personalised peptide vaccines
- Evaluating HLA genotype as predictive biomarker for in vitro measured immunogenicity of peptide vaccines
- Showcasing correlation studies for the identification of a candidate predictive biomarker
